椎間板変性症のヤギのモデルにおける神経免疫活性化
Janai A Augustin1,2,3, Kevin G Burt1,2,4, Caitlin Barrett2,5
1Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Cells
|February 12, 2026
まとめ
椎間板変性 (IVDD) は痛みを引き起こします. 大型の動物モデルでは,コンドロイチナゼABC (ChABC) の注射がIVDDを誘発し,神経炎症と機械機能の低下につながり,新しい治療法を試験するためにその使用を検証することを示しました.
科学分野:
- バイオメディカルエンジニアリング
- 神経科学は神経科学である.
- 整形外科 整形外科 整形外科
背景:
- 椎間板変性 (IVDD) は慢性疼痛の主な原因である.
- 小型の動物モデルは,ヒトの脊髄の解剖学と生理学の研究に限界があります.
- トランスレーション研究のためにヒトIVDDを正確に複製するには,大型動物モデルが必要です.
研究 の 目的:
- コンドロイチナゼABC (ChABC) を使用した大型動物モデルで子宮頸椎盤変性を誘発する.
- IVD,脊髄,背骨の根のガンリア (DRG) のディスク病理および神経炎症反応を評価する.
- ディスク変性,免疫応答,神経活性化との間の定量的な関係を確立する.
主な方法:
- 大型の動物モデルで,腸内クロンドロイチナゼABC (ChABC) の注射によって誘発された子宮頸椎椎間板変性.
- 構造的変化や隣接セグメント変性を含むディスク病変の評価.
- インナーベーションのマーカー (PGP9.5,NFH),モノサイト (Ly6C),マクロファージ (CD68),マイクログリア (Iba1) および物質Pを使用した神経炎症分析.
主要な成果:
- ChABCの注射は,構造的変性および隣接セグメント変性を引き起こしました.
- 変性IVDでは内置とモノサイト/マクロファージマーカー (Ly6C,CD68) の増加が観察されました.
- IVDにおけるP物質の増加は,機械的完全性の低下と相関しています.
- 脊髄におけるマイクログリア (Iba1) と物質Pの増加とDRGsは神経炎症を示した.
結論:
- この研究では,ヒトの状態をよく真似した,ChABC誘発のIVDDの大型動物モデルを検証しました.
- モノサイト/マクロファージおよびマイクログリアの活性化を含む神経炎症は,ディスク変性症の重要な構成要素です.
- このモデルは,IVDDおよび関連する痛みに対する再生および治療戦略の臨床前評価に適しています.
関連する概念動画
Design Example: Calculating Safe Diameter for Wind-Exposed Disc
363
Assessing safety in wind-exposed installations is crucial to preventing potential failures. This example explores the calculation and design adjustments needed to mount a circular disc on a building facade, where wind forces are a primary concern. A 4-meter diameter disc was initially designed as an aesthetic feature facing winds at a velocity of 25 meters per second, with an air density of 1.25 kilograms per cubic meter. Given these conditions, the drag force on the disc was determined using...
363
Co-activators and Co-repressors
8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
tRNA Activation
23.1K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.1K
Activation Energy
87.1K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
87.1K
Eukaryotic Transcription Activators
12.9K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.9K
Secondary Active Transport
138.2K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
138.2K


